Drug conjugates (ADCs) developed at Institute of Science Tokyo combine a CD4 mimic with neutralizing antibodies for enhanced suppression of human immunodeficiency virus (HIV) infection. By targeting ...

Scientists isolated and grew rare HIV reservoir clones that allow the virus to persist despite therapy. The study shows that ...

One-third of children with HIV who received very early ART had no detectable virus in their body for at least 12 weeks after stopping treatment, according to study findings. It was another sign that ...

Advancements in HIV/AIDS research, drug development, and clinical practice since the 1980s have made it possible for people living with HIV to lead long, productive lives and keep the virus in check ...